International Clinical Trial: Effectiveness and safety of riluzole for the treatment of seizures in individuals with SCN8A developmental and epileptic encephalopathy (SCN8A-DEE)

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000845437) titled 'Effectiveness and safety of riluzole for the treatment of seizures in individuals with SCN8A developmental and epileptic encephalopathy (SCN8A-DEE)' on Aug. 6.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Blinded (masking used) Assignment: Crossover Type of endpoint: Safety/efficacy

Primary Sponsor: University of Melbourne

Condition: SCN8A developmental and epileptic encephalopathy SCN8A developmental and epileptic encephalopathy Neurological - Epilepsy Human Genetics and Inherited Disorders - Other human genetics and inherited disorders

Int...